Regulation of [Ca++](i) in human neuroblastoma (SH-SY5Y) cells expressing recombinant rat angiotensin(1A) receptors by angiotensin II and carbachol

Journal of Pharmacology and Experimental Therapeutics

Volumn 281, Issue 3, 1997, Pages 1257-1263

  McDonald, R L ^a   Roberts, D J ^a   Palmer, A C V ^a   Ball, S G ^a   Vaughan, P F T ^a   Peers, C ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN RECEPTOR; CARBACHOL; MECAMYLAMINE; MUSCARINIC RECEPTOR; NICOTINIC RECEPTOR; THAPSIGARGIN;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONTROLLED STUDY; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; PRIORITY JOURNAL; REGULATORY MECHANISM; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ANGIOTENSIN II; ANIMALS; CALCIUM; CARBACHOL; CELLS, CULTURED; HUMANS; NEUROBLASTOMA; RATS; RECEPTORS, ANGIOTENSIN; RECOMBINANT PROTEINS;

EID: 0030911214     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. 2+. FEBS Lett. 242: 337-340, 1989.
2. 1A receptor. Eur. J. Pharmacol. 291: 135-141, 1995.
3. BROWN, D. A., CONSTANTI, A. AND MARSH, S.: Angiotensin mimics the action of muscarinic agonists on rat sympathetic neurones. Brain Res. 193: 614-619, 1980.
4. CICCARONE, V., SPENGLER, B. A., MEYERS, M. B., BIEDLER, J. L., AND ROSS, R. A.: Phenotypic diversification in human neuroblastoma cells: expression of distinct neural crest lineages. Cancer Res. 49: 219-225, 1989.
5. CONNOR, M. AND HENDERSON, G.: δ-and μ-opioid receptor mobilization of intracellular calcium in SH-SY5Y human neuroblastoma cells. Br. J. Pharmacol. 117: 333-340, 1996.
6. 2+ influx: How many mechanisms for how many channels? Trends Pharmacol. Sci. 15: 77-83, 1994.
7. FORSYTHE, I. D., LAMBERT, D. G., NAHORSKI, S. R., AND LINDSDELL, P.: Elevation of cytosolic calcium by cholinoceptor agonists in SH-SY5Y human neuroblastoma cells: estimation of the contribution of voltage-dependent currents. Br. J. Pharmacol. 107: 207-214, 1992.
8. GOULD, J., REEVE, H. L., VAUGHAN, P. F., AND PEERS, C.: Nicotinic acetylcholine receptors in human neuroblastoma (SH-SY5Y) cells. Neurosci. Lett. 145: 201-204, 1992.
9. 2+ entry following store depletion in SH-SY5Y neuroblastoma cells. Mol. Brain Res. 36: 93-100, 1996.
10. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260: 3440-3450, 1985.
11. HUGHES, A. D. AND SCHACHTER, M.: Multiple pathways for entry of calcium and other divalent cations in a vascular smooth muscle cell line (A7r5). Cell Calcium. 15: 317-330, 1994.
12. 2+ entry pathways are activated by muscarinic receptor stimulation in a human submandibular ductal cell line. Pfugers Arch. 428: 439-445, 1994.
13. 2+ and inositol 1,4,5-trisphosphate mass in a human neuroblastoma cell line, SH-SY5Y. Biochem. J. 265: 555-562, 1990.
14. LAMBERT, D. G. AND NAHORSKI, S. R.: Carbachol-stimulated calcium entry in SH-SY5Y human neuroblastoma cells: which route? J. Physiol. (Paris) 86: 77-82, 1992.
15. 2+ induced by depolarization and muscarinic receptor stimulation in SH-SY5Y human neuroblastoma cells. Mol. Brain Res. 8: 263-266, 1990.
16. MATSUKAWA, S. AND REID, I. A.: Role of the area postrema in the modulation of the baroreflex control of heart rate by angiotensin II. Circ. Res. 67: 1462-1473, 1990.
17. MCDONALD, R. L., BALMFORTH, A. J., PALMER, A. C., BALL, S. G., PEERS, C., AND VAUGHAN, P. F. T.: The effect of the angiotensin II (AT1A) receptor stably transfected into human neuroblastoma SH-SY5Y cells on noradrenaline release and changes in intracellular calcium. Neurosci. Lett. 199: 115-118, 1995a.
18. 3H]noradrenaline from the human neuroblastoma SH-SY5Y. Biochem. Pharmacol. 48: 23-30, 1994a.
19. 1A receptor. Br. J. Pharmacol. 116: 299P, 1995b.
20. 2+ channels. Br. J. Pharmacol. 113: 621-627, 1994b.
21. 3H]noradrenaline from human neuroblastoma cells, SH-SY5Y. J. Neurochem. 56: 1810-1815, 1991a.
22. MURPHY, N. P., VAUGHAN, P. F. T., BALL, S. G., AND MCCORMACK, J. G.: The cholinergic regulation of intracellular calcium in the human neuroblastoma, SH-SY5Y. J. Neurochem. 57: 2116-2123, 1991b.
23. OGINO, Y. AND COSTA, T.: The epithelial phenotype of human neuroblastoma cells express bradykinin, endothelin, and angiotensin II receptors that stimulate phosphoinositide hydrolysis. J. Neurochem. 58: 46-56, 1992.
24. PEACH, M. J., CLINE, W. H. AND WATTS, D. T.: Release of adrenal catecholamines by angiotensin II. Circ. Res. 19: 571-575, 1996.
25. 3H] noradrenaline from SH-SY5Y cells. J. Neurochem. 64: 1175-1182, 1995.
26. REEVE, H. L., VAUGHAN, P. F. T., AND PEERS, C.: Calcium channel currents in undifferentiated human neuroblastoma (SH-SY5Y) cells: Actions and possible interactions of dihydropyridines and mega-conotoxin. Eur. J. Neurosci. 6: 943-952. 1994.
27. 2+ channel currents in human neuroblastoma (SH-SY5Y) cells by muscarine via stimulation of M, receptors. Neuropharmacology 34: 319-326, 1995.
28. REID, I. A.: Interactions between ANG II, sympathetic nervous system, and baroreceptor reflexes in regulation of blood pressure. Am. J. Physiol. 262: E763-E778, 1992.
29. 2+-ATPase. Proc. Natl. Acad. Sci. U.S.A. 87: 2466-2470, 1990.
30. TIMMERMANS, P. B. M. W. M., WONG, P. C., CHIU, A. T., HERBLIN, W. F., BENFIELD, P., CARINI, D. J., LEE, R. J., WEXLER, R. R., SAYE, J. A., AND SMITH, R. D.: Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol. Rev. 45: 205-251, 1993.
31. 3H]noradrenaline release from the human neuroblastoma SH-SY5Y. Eur. J. Neurosci. 7: 875-880, 1995a.
32. VAUGHAN, P. F. T., KAYE, D. F., REEVE, H. L., BALL, S. G., AND PEERS, C.: Nicotinic receptor-mediated release of noradrenaline in the human neuroblastoma SH-SY5Y. J. Neurochem. 60: 2159-2166, 1993.
33. VAUGHAN, P. F. T., PEERS, C. AND WALKER, J. H.: The use of the human neuroblastoma SH-SY5Y to study the effect of second messengers on noradrenaline release. Gen. Pharmacol. 26: 1191-1201, 1995b.
34. WONG, P. C., HART, S. D., ZASPEL, A. M., CHIU, A. T., ARDECKY, R. J., SMITH, R. D., AND TIMMERMANS, P. B. M. W. M.: Functional studies of nonpeptide angiotensin II receptor subtype-specific ligands: DuP 753 (AII-1) and PD123177 (AII-2). J. Pharmacol. Exp. Ther. 255: 584-592, 1990.
35. ZIMMERMANN, J. B., ROBERTSON, D. AND JACKSON, E. K.: Angiotensin II noradrenergic interactions in renovascular hypertensive rats. J. Clin. Invest. 80: 443-457, 1987.